Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • seq-ngs
    Junior Member
    • Sep 2014
    • 3

    Library Prep for Cancer NGS

    Hi all,

    I am designing several cancer panels to run on the MiSeq. Each panel consists of 600-800 amplicons - approximately 150 bp each. What I am pondering right now is the library prep method to use. There are 5 main options:

    1. Illumina - TSCA
    2. Life Tech - AmpliSeq
    3. Agilent - Haloplex
    4. NuGen
    5. Qiagen

    We deal with formalin-fixed, paraffin-embedded samples that are degraded and often of low DNA quantity/quality. I like Ampliseq better than TSCA because it is multiplex PCR rather than probe hybridization (like Illumina) but don't want to run Ampliseq on the MiSeq because the Life Tech people seem not to like that. Any thoughts on a good library prep method from the choices above for FFPE samples? Thanks so much for any input.
  • shrutimish@gmail.com
    Member
    • Dec 2012
    • 12

    #2
    I would also like to know more about why Life Tech does not like Ampliseq on the Miseq?

    Comment

    • pmiguel
      Senior Member
      • Aug 2008
      • 2328

      #3
      Originally posted by [email protected] View Post
      I would also like to know more about why Life Tech does not like Ampliseq on the Miseq?
      What makes you think that this is the case?

      Life Tech has their own sequencer, by the way.

      --
      Phillip

      Comment

      • shrutimish@gmail.com
        Member
        • Dec 2012
        • 12

        #4
        I asked this question "Life Tech does not like Ampliseq on the Miseq" because the previous person commented that. So, do you think it is not an issue? Can we actually use Ampliseq for target enrichment and run it on MiSeq?
        Also, when you say life tech has their own sequencer- Are you talking about the Ion torrent sequencer?

        Thanks in advance for answering these questions.

        Comment

        • thomasblomquist
          Member
          • Jul 2012
          • 68

          #5
          I do it all the time. I have my target specific primers with "tails on them." These tails are "universal" sequences alien to the genome your targeting. I then add on the "platform" specific P5/P7 tails with R1/R2 priming regions for Illumina, or the Forward and Reverse sequencing tails for Ion Torrent to complete the job.

          Wham bam, the results that get spit out (for genotyping purposes) are pretty much similar.

          Now, and this is a big IF, you are trying to QUANTIFY rare alleles, the detection limits for that give base variation between the different loci will be HIGHLY PLATFORM DEPENDENT.

          For the most part Illumina Error profile is quite good. And cost wise, is easier/cheaper to get up and running. Ion Torrent with its heterodimer bead issues can create problems with similar templates that vary by a single allele; especially in low complexity libraries.

          Ion torrent, if done right, can have a VERY QUICK turn around, and can be used for quick identification once the assay is well characterized.

          Best of luck.

          -Tom Blomquist

          Comment

          • shrutimish@gmail.com
            Member
            • Dec 2012
            • 12

            #6
            Thanks Tom for your reply. It is very useful to know this.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            28 views
            0 reactions
            Last Post SEQadmin2  
            Working...